-
Publication Venue For
-
Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-Response..
63:105-118.
2023
-
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study..
62:220-231.
2022
-
Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent..
61:1232-1242.
2021
-
Optimal Dosing of Meropenem in a Small Cohort of Critically Ill Children Receiving Continuous Renal Replacement Therapy..
61:744-754.
2021
-
Pharmacokinetics of Hydrochlorothiazide in Children: A Potential Surrogate for Renal Secretion Maturation..
61:368-377.
2021
-
Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic Analysis..
60:636-647.
2020
-
Randomized Population Pharmacokinetic Analysis and Safety of Intravenous Acetaminophen for Acute Postoperative Pain in Neonates and Infants..
60:16-27.
2020
-
Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents..
59:1606-1619.
2019
-
Methadone Disposition: Implementing Lessons Learned..
59:1044-1048.
2019
-
A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers..
59:717-730.
2019
-
Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children..
58 Suppl 10:S58-S72.
2018
-
Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children..
58:1092-1104.
2018
-
Population Pharmacokinetics of Dexmedetomidine in Infants..
57:1174-1182.
2017
-
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects..
57:770-776.
2017
-
Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery..
57:712-719.
2017
-
Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure..
57:440-451.
2017
-
Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation..
57:230-234.
2017
-
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia..
56:298-306.
2016
-
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia..
56:176-185.
2016
-
Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis..
55:39-44.
2015
-
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF..
54:917-927.
2014
-
Role of cytochrome P4502B6 in methadone metabolism and clearance..
53:305-313.
2013
-
Developmental pharmacokinetic changes of Lamivudine in infants and children..
52:1824-1832.
2012
-
Effects of BG9928, an adenosine A₁ receptor antagonist, in patients with congestive heart failure..
51:899-907.
2011
-
Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast..
51:751-760.
2011
-
Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases..
50:714-720.
2010